Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Main Authors: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/1/3 |
Similar Items
-
RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
by: Jonas B. Sandbrink, et al.
Published: (2020-12-01) -
Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
by: Yoann Aldon, et al.
Published: (2021-09-01) -
New Vaccine Technologies to Combat Outbreak Situations
by: Susanne Rauch, et al.
Published: (2018-09-01) -
Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
by: Yu-Jing Fan, et al.
Published: (2021-09-01) -
DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies
by: A. A. Goryaev, et al.
Published: (2019-06-01)